---
layout: post
title: "中恒集团：子公司药品拟中标中成药省际联盟集中带量采购"
date: 2021-12-22 18:09:30 +0800
categories: zhengquanshibao
tags: 证券时报新闻
---
<!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/1.600252" data-code="600252|1|1" data-code2="600252|1|2|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=1.600252&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 600252_0" data-code="K 600252|1|1" data-code2="K 600252|1|2|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>中恒集团(600252)12月22日晚间公告，公司核心子公司梧州制药产品注射用血栓通(冻干)拟中标中成药省际联盟集中带量采购。</p><p class="em_media">（文章来源：证券时报）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202112222222942586>

[返回证券时报新闻](//finews.withounder.com/category/zhengquanshibao.html)｜[返回首页](//finews.withounder.com/)